How severe is CVE-2024-38317?

CVE-2024-38317 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2024-38317 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-38317?

CVE-2024-38317 primarily affects Ibm Aspera Shares. In total, 8 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2024-38317?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-38317 have an EU (EUVD) identifier?

Yes. CVE-2024-38317 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-37116.

When was CVE-2024-38317 published?

CVE-2024-38317 was published on 2025-02-05 and last updated on 2026-06-17.

CVE-2024-38317

CVE-2024-38317 is a medium-severity vulnerability in Ibm Aspera Shares with a CVSS 3.x base score of 4.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 4.8)
EPSS exploit prediction: 0% (12th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-37116
Weakness: CWE-79
Affected product: Ibm Aspera Shares
Published: 2025-02-05
Last modified: 2026-06-17

Description

IBM Aspera Shares 1.9.0 through 1.10.0 PL6 is vulnerable to cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Frequently asked questions

What is CVE-2024-38317?: IBM Aspera Shares 1.9.0 through 1.10.0 PL6 is vulnerable to cross-site scripting. This vulnerability allows a privileged user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
How severe is CVE-2024-38317?: CVE-2024-38317 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-38317 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (12th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-38317?: CVE-2024-38317 primarily affects Ibm Aspera Shares. In total, 8 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2024-38317?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-38317 have an EU (EUVD) identifier?: Yes. CVE-2024-38317 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-37116.
When was CVE-2024-38317 published?: CVE-2024-38317 was published on 2025-02-05 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7182490

Affected products (8)

cpe:2.3:a:ibm:aspera_shares:*:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:-:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level1:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level2:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level3:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level4:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level5:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_shares:1.10.0:patch_level6:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Shares

CVE-2025-0162 — High (CVSS 7.1): IBM Aspera Shares 1.9.9 through 1.10.0 PL7 is vulnerable to an XML external entity injection (XXE) attack when…
CVE-2024-56472 — Medium (CVSS 6.4): IBM Aspera Shares 1.9.0 through 1.10.0 PL6 is vulnerable to stored cross-site scripting. This vulnerability allows…
CVE-2025-66483 — Medium (CVSS 6.3): IBM Aspera Shares 1.9.9 through 1.11.0 does not invalidate session after a password reset which could allow an…
CVE-2024-38315 — Medium (CVSS 6.3): IBM Aspera Shares 1.0 through 1.10.0 PL3 does not invalidate session after a password reset which could allow an…
CVE-2023-38018 — Medium (CVSS 6.3): IBM Aspera Shares 1.10.0 PL2 does not invalidate session after a password change which could allow an authenticated…
CVE-2020-4731 — Medium (CVSS 6.1): IBM Aspera Web Application 1.9.14 PL1 is vulnerable to cross-site scripting. This vulnerability allows users to embed…

All CVEs affecting Ibm Aspera Shares →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →